Paul F. Reid
Keine laufenden Positionen mehr
Profil
Paul F.
Reid was the founder of ReceptoPharm, Inc. founded in 2001, where he held the title of Chief Executive Officer from 2009 to 2011.
He was also the Chief Executive Officer of Nutra Pharma Corp.
from 2008 to 2010 and held the title of Head-Scientific Affairs at Biotherapeutics, Inc. in 1993.
Dr. Reid obtained a doctorate degree from Imperial College London and an undergraduate degree from Trinity College Dublin in 1987.
Ehemalige bekannte Positionen von Paul F. Reid
Unternehmen | Position | Ende |
---|---|---|
NUTRA PHARMA CORP. | Präsident | 18.11.2009 |
Biotherapeutics, Inc.
Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Corporate Officer/Principal | 01.01.1993 |
ReceptoPharm, Inc.
ReceptoPharm, Inc. Pharmaceuticals: MajorHealth Technology ReceptoPharm, Inc. develops proprietary therapeutic protein products for the prevention and treatment of viral and neurological diseases. It provides benefits for patients with such diseases as acquired immunodeficiency syndrome, multiple sclerosis, myasthenia gravis, and other viral disorders. The company was founded on June 4, 2001 and is headquartered in Plantation, FL. | Vorstandsvorsitzender | - |
Ausbildung von Paul F. Reid
Imperial College London | Doctorate Degree |
Trinity College Dublin | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NUTRA PHARMA CORP. | Retail Trade |
Private Unternehmen | 2 |
---|---|
ReceptoPharm, Inc.
ReceptoPharm, Inc. Pharmaceuticals: MajorHealth Technology ReceptoPharm, Inc. develops proprietary therapeutic protein products for the prevention and treatment of viral and neurological diseases. It provides benefits for patients with such diseases as acquired immunodeficiency syndrome, multiple sclerosis, myasthenia gravis, and other viral disorders. The company was founded on June 4, 2001 and is headquartered in Plantation, FL. | Health Technology |
Biotherapeutics, Inc.
Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Health Technology |